Healthcare Distribution Alliance – Patients Move Us.
Share Print
DMC 2017


DMC and Expo | March 5-8 | Palm Desert, Calif.


Christopher Anderson  
Christopher J. Anderson, Director, Quality Systems, , Cardinal Health, Inc.

Chris has been with Cardinal Health since 1987 in Quality and Regulatory Affairs, at both the field and corporate levels, responsible for wholesale drug distribution compliance. Over the past ten years, he has built a quality system supporting the Pharmaceutical Distribution business.

Chris led the development of the current innovative and sustainable cold chain packaging process for Cardinal Health that has been recognized through the industry through various awards, speaking invitations and publications.

In his quality role, Chris has regulatory responsibility for the quality systems that support compliance, temperature management and DSCSA regulatory support.

Chris was a member of the United States Pharmacopeia (USP) Packaging and Distribution Expert Committee Member.

He holds a Bachelor of Arts degree from Norwich University in Political Science and a Master of Arts degree in Organizational Behavior.

Demetra Ashley  
Demetra Ashley, Deputy Assistant Administrator, Office of Diversion Control, , U.S. Drug Enforcement Administration (DEA)

Dina Barton  
Dina M. Barton, Director, Contracts and Chargebacks Administration, , AmerisourceBergen Corporation

Dina Barton is the Director of Contracts and Chargebacks Administration at AmerisourceBergen. During her 17-year tenure at AmerisourceBergen, she has held various leadership positions within Contracts and Chargebacks. Dina is responsible for the creation, implementation and execution of strategic goals that are designed to deliver positive contract and chargeback administration performance through effective information sharing and process reengineering with strong emphasis on operational efficiency and Customer Care.

Dina has been involved in Six Sigma and leadership projects which resulted in significant process improvements for both AmerisourceBergen and pharmaceutical suppliers. Under Dina’s leadership, ABC successfully implemented a new contract pricing system. Dina was responsible for the system design, training and key conversion activities as a member of the Business Transformation team.

Dina is a current member of the HDA Contracts and Chargebacks Working Group.

Nathan Bland  
Nathan Bland, Senior Manager, U.S. Gross to Net Operations, , Pfizer Inc.

Nathan Bland is a Senior Manager responsible for the Gross to Net organization in Pfizer Shared Services. In this role, he leads a team of finance professionals managing complex Gross to Net processes and is responsible for all elements of process design, execution, compliance and governance of the Chargeback, Membership and Medicaid organizations.

Nathan joined Pfizer in 2010 and has played a key role in a number of significant projects including the divestitures of the Capsugel, Animal Health and Nutrition businesses, the deployment of the SAP ERP Platform, the Wyeth and King acquisitions, the standup of the Financial Reporting Project and the transformation of the global E2E balance sheet reconciliation process as the Global Lead for the Balance Sheet Globalization Program.

Prior to joining Pfizer, Nathan worked for 5 years in Deloitte's audit department, focusing on SEC filers and financial institutions. He has extensive experience in Sarbanes Oxley implementation and financial statement preparation. He is a Certified Public Accountant and holds a Bachelors of Business Administration in Accounting from Harding University in Searcy, Arkansas.

Scott Bradford  
Scott Bradford, Owner/Principal, , Bradford Rx Solutions, LLC

Scott Bradford is currently the owner of Bradford Rx Solutions, a supply chain consulting firm he started in 2013. His consultancy focuses on improving financial results for various partners in pharmaceutical distribution including manufacturers, reverse distributors, wholesalers and healthcare providers. Bradford Rx Solutions has identified multi-million dollar net financial benefits to several clients and actively partners to implement improvements to business processes and models.

Prior to this consulting role, Scott worked at McKesson Corporation. During his most recent role at McKesson as Vice President of Reverse Logistics, Scott managed $2.4 billion annual returns process for pharmaceutical products developing return policies and procedures, managing third party vendor relationships and contracts related to returns processing and financial services, and driving growth in gross profit. Having profit and loss accountability for comprehensive returns processes, Scott and his team delivered $75 million annual value to shareholders and significantly expanded gross profit while managing the reverse logistics operation. He began his career at McKesson in 1993 in financial planning/analysis, transitioned in 1996 to a Regional Controller in pharmaceutical distribution, and subsequently held the titles of Vice President for Accounts Payable, Vice President for Chargebacks Reconciliation and Director of Reverse Logistics before serving as Vice President of Reverse Logistics for 11 years from 2002 to 2013.

Scott received his Bachelor of Science in Business Administration from the University of California, Berkeley.

Daniel Burke  
Daniel Burke, CCFP, Senior Special Agent, Senior Operations Manager, Office of Criminal Investigations, , U.S. Food and Drug Administration

Special Agent Dan Burke started his federal law enforcement career with the IRS-Criminal Investigation Division in 1995. In 1997, he transferred to the U.S. Customs Service, where he primarily investigated online child pornography, drug and financial investigations. In 2002, he was promoted to Supervisory Special Agent for U.S. Customs, which is now known as ICE’s-Homeland Security Investigations, where he managed a Financial Investigations Task Force. In 2005, Dan joined FDA’s Office of Criminal Investigations (OCI).

During his career, Dan has completed a number of successful cybercrime investigations spanning the globe and is also part of OCI’s cadre of digital forensics specialists. In 2012, Dan was promoted to Manager of the Cybercrimes Investigation Unit (CcIU) and is also overseeing the development of OCI’s international expansion and liaison efforts. Dan has attained a variety of certifications in the field of digital and cyber-forensics, is listed on the United Nations Security Council Roster of Experts and holds a master's degree in Criminal Justice Administration from the University of Colorado-Denver where he is currently a member of their adjunct faculty.

Marijo Bustos  
Marijo G. Bustos, Director, Government Programs and Commercial Compliance, , Prometic Biotherapeutics

Marijo Bustos is the Manager of Chargebacks with Fresenius Kabi USA located in Lake Zurich, Illinois. Marijo began her tenure with Fresenius Kabi USA in Government Pricing and Compliance. She spent twelve years ensuring the accurate and compliant reporting of government regulated pharmaceutical pricing and the corresponding impact analysis from market introduction to profit analysis.

Marijo’s focus during the last five years has been the implementation of Chargeback processes and reporting to ensure accurate and timely responses to pharmaceutical chargeback requests and confirm data integrity and transparency for sales and financial analysis. She led several projects on system implementations (SAP, Imany/Revitas, and Model N) and government program implementations (340B pricing and membership validation, Medicaid rebate claims, Medicaid AMP, Medicaid BP, Medicare ASP, Veterans Administration Non-FAMP, Department of Defense Tricare rebate claims).

Marijo is a leader in class of trade determination, chargeback process management, commercial contract compliance, product life cycle management, government pricing programs, government contracts, gross to net profit analysis and system integration management.

BJ Centers  
BJ Centers, Senior Director, Contract Services, , Apexus, LLC

BJ Centers is Senior Director of Distributor Contracting at Apexus, the HRSA-designated 340B Prime Vendor, where he oversees relationships with 28 authorized distributors to ensure that covered entities have access to 340B drugs. In this role, he supports wholesalers and distributors in 340B compliance issues and challenges as it relates to the supply chain. BJ also manages the Apexus Manufacturer Refund Service, facilitating manufacturer refunds of 340B pricing overcharges to covered entities in the form of credits through covered entity distributor pharmacy ordering accounts.

Throughout his 40-year career, working with group purchasing organizations in the healthcare industry, BJ has served in sales, operations and management roles at pharmaceutical wholesalers. He has held various management positions at both large and small pharmaceutical manufacturers, where he was responsible for national and managed accounts. His specialties include: controlled distribution service development; real-time unit-dosing strategies; acute and non-acute care class of trade program/service development; web-based contract compliance and procurement modeling; government contracting; and securing national contracts for brand and generic pharmaceuticals.

Theodore Cicero  
Theodore J. Cicero, John P Feighner Professor of Psychiatry, , Washington University

Theodore J. Cicero received his PhD in 1968 from Purdue University and joined the faculty at Washington University School of Medicine as an Assistant Professor in 1970. He is now the John P. Feighner Professor of Psychiatry. Dr. Cicero has published over 200 scientific articles in the general area of substance abuse research. Much of his work has focused on neurobiological substrates of dependence and abuse of drugs (opiates and alcohol) in animal models. More recently, over the past 15 years, his focus has been on the epidemiology of opiate abuse, beginning with the emergence of the prescription drug problem in the 1990’s to the recent transition of heroin abuse from an inner city problem in poor, minority males to an epidemic in white, middle class male and female residents of suburban and rural locations.

Christopher Clement  
Christopher Clement, Senior Portfolio Executive, , Apexus, LLC

Chris has worked for Apexus going on four years, and is responsible for many of Apexus’ key authorized distributor partners, as well as the Apexus Generics Program, and educating industry partners around 340B and the Prime Vendor Program. He continues to expand his impact within the Prime Vendor through his collaboration with the education team and the award-winning 340B University OnDemand training program. Chris also has recently become a 340B Apexus Certified Expert (ACE).

Prior to joining Apexus, Chris built his career through 13 years with AmerisourceBergen as a subject matter expert on the generic pharmaceutical marketplace, as well as a field sales coach, trainer, analyst and key account contact. His diverse background in the wholesaler industry gives him unique insight into the generics marketplace, and in understanding the distributor/340B relationship.

David Colombo  
David Colombo, Director, Life Sciences Advisory Services, , KPMG, LLP

David Colombo is a Director in KPMG’s Advisory Services practice with more than 25 years of operational, engineering and IT experience in supply chain execution in the pharmaceutical industry, including both clinical and commercial chains. His responsibilities range from defining solution strategy through implementation with focus on order-to-cash and purchase-to-pay processes, warehousing and distribution operations, and supply chain security.

Prior to joining KPMG in 2013, David was the serialization implementation leader for a Top-10 global pharmaceutical company. His industry experience included technical and operational leadership positions in supply chain, distribution, information technology and clinical trials logistics. He was an active contributor as a member of the EFPIA/ESM serialization technical work stream, the HDMA bar coding task force and the PDSA consortium. He has implemented serialization and traceability solutions in Turkey, China, Spain, Argentina and the U.S. in response to current and emerging requirements, leveraging his experience with ERP systems, WMS/TMS applications and GS1 standards for product and location identification.

David currently supports pharmaceutical manufacturers, distributors and dispensers with their product serialization and traceability programs, as well as medical device manufacturers with Unique Device Identification (UDI) implementation efforts.

Peter Connor  
Peter Connor, McKesson EDI, , McKesson Corporation

Peter Connor has been with McKesson Corporation for nine years, during which time he has been instrumental in completing multiple key industry initiatives and requirements including CSOS, EDI chargeback and contracts, DSCSA serialization and sales and inventory analytics. He has a deep strategic knowledge of industry processes coupled with hands-on, real world experience.

Prior to McKesson, Peter worked for eight years as an onsite consultant for EDI software maker, Sterling Commerce, where he developed, installed and supported EDI systems for Fortune 500 firms on a variety of platforms and throughout several industries.

Brian Daleiden  
Brian Daleiden, Vice President of Industry Marketing, , TraceLink Inc.

Brian is Vice President of Industry Marketing and Co-Founder at TraceLink Inc. In this capacity, Brian guides thought leadership, global regulatory analysis, standards engagements, solution marketing and market education programs that help industry stakeholders protect patient safety and meet global compliance requirements across the global pharmaceutical supply chain. Brian also leads the TraceLink Cloud Community, the company’s network of industry leaders spanning all segments of the global life sciences supply network.

Previously, Brian led product and corporate marketing at SupplyScape, additionally holding numerous marketing and software development leadership roles in the manufacturing and supply chain space at Catalyst International, Rockwell Automation and several startup companies.

Brian holds an MBA from Vanderbilt University and a BS from the University of Wisconsin.

Jeffery Denton  
Jeffery W. Denton, Senior Director, Global Secure Supply Chain, , AmerisourceBergen Corporation

Jeff Denton is currently Senior Director, IT Global Secure Supply Chain at AmerisourceBergen. With over 30 years of experience in the wholesale distribution business, Jeff has held positions of increasing responsibility in finance, procurement, contracts and chargebacks as well as Information Technology.

Over the last 12 years, Jeff has been very involved in a variety of aspects around the supply chain security initiative. In addition, he has participated in numerous standards-activities within HDMA and GS1-US/Global.

His current responsibilities include Enterprise IT solutions for AmerisourceBergen’s Global Secure Supply Chain program. Jeff serves at the IT lead and is the key liaison across all of the various business units – aligning implementation with standardization.

Matthew DiLoreto  
Matthew DiLoreto, Vice President, State Government Affairs, , Healthcare Distribution Alliance

As HDA’s Vice President, State Government Affairs, Matthew DiLoreto coordinates HDA's nationwide state government affairs efforts, while maintaining and developing relationships with key stakeholders as well as state policymakers and law makers throughout the country. Matt also coordinates closely with HDA’s members to develop, implement and execute effective advocacy strategies addressing state legislative and regulatory issues affecting the pharmaceutical supply chain.

Prior to joining the HDA team, DiLoreto served as the Senior Director of State Government Affairs for the National Community Pharmacists Association (NCPA) which represents the interests of approximately 22,000 pharmacy providers and owners nationwide. His responsibilities at NCPA included developing and executing NCPA's state legislative strategy, while working closely with the association's many state and federal partners across the nation. DiLoreto also was a registered federal lobbyist and actively advanced many of NCPA's federal legislative and regulatory initiatives. During his years at NCPA DiLoreto was responsible for supporting state efforts resulting in more than fifty enacted state laws based upon NCPA model state legislation. Such laws primarily focused on reforming pharmacy reimbursement and drug pricing practices, and on providing for a fair and accessible medication delivery marketplace.

Before moving to the Washington D.C. area, Matt advocated for the Pennsylvania Pharmacists Association in Harrisburg, Pennsylvania, as the Director, Government Affairs and also represented the Pennsylvania Dental Association.

Christopher Doerr  
Christopher R. Doerr, Vice President, Trade Relations & Distribution Strategy, , Teva Pharmaceuticals USA

Chris Doerr has been in the pharmaceutical industry for almost 20 years and is currently the Senior Director, Trade Operations at Teva Pharmaceuticals. Chris’ team is responsible for managing the strategic relationships with wholesalers, distributors, specialty distributors, retail and specialty pharmacies. In addition to responsibility for national accounts, Chris is responsible for developing and implementing the appropriate channel strategy for all Teva specialty medicines launched commercially in the U.S.

Prior to joining Teva, via the acquisition of Cephalon, Chris was the Associate Director of Client Financial Services at Cephalon. In this role, Chris was responsible for overseeing trade relations, credit and accounts receivable and logistics. Previous to Cephalon, Chris spent six years in roles of increasing responsibility within supply chain, procurement and finance at AmerisourceBergen.

Chris received his bachelor's degree in Finance from Albright College. He received a master’s degree in Pharmaceutical Marketing from the Erivan K. Haub School of Business at St. Joseph’s University.

Anita Ducca  
Anita T. Ducca, Senior Vice President, Regulatory Affairs, , Healthcare Distribution Alliance

Anita T. Ducca is HDA’s Senior Vice President of Regulatory Affairs. She serves as the chief liaison and advocate on behalf of HDA with federal regulatory agencies, including FDA and DEA. She has been with the organization since 2002.

Prior to joining HDA, Ms. Ducca was the Director of Regulatory Affairs for the American Red Cross Biomedical Services (ARC), where she was responsible for internal and external regulatory, compliance and health and safety. Anita also served in a regulatory advocacy capacity for the American Petroleum Institute. Earlier, she has also served on the staff of several federal regulatory agencies, including the Food and Drug Administration, the Office of Management and Budget and the Environmental Protection Agency.

Ducca has a BA in Mathematics from Boston College and a MS in Biostatistics from Georgetown University.

Chad Ducote  
Chad E. Ducote, Senior Director, Health and Wellness Logistics, , Wal-Mart Pharmacy

Chad Ducote is currently the Senior Director for Health and Wellness Logistics. In this role he is responsible for strategic, operational, financial, transportation, regulatory compliance and human resource-related functions in Walmart’s pharmaceutical supply chain. Walmart Stores, Inc. is the largest retailer in the world with over 7200 facilities operating in 15 countries and employing more than 2 million associates.

Chad joined Walmart in 1992 as an hourly Associate upon return from active military duty. From 1992 through 2014, Chad steadily progressed through Walmart’s management ranks. These positions included Pharmacy Manager, Manager of Professional Recruiting, Director of Specialty Group Training, Regional Compliance Manager, Divisional Compliance Director and General Manager of Walmart Regional Distribution Center 6048.

Chad graduated Magna cum laude with a B.S in Pharmacy from the University of Louisiana at Monroe, then went on to receive his M.S. in Pharmacy Regulation and Policy from the University of Florida. From there Chad went on to receive his M.B.A. focused on the pharmacy industry from Stetson University.

In 2007, Chad was recognized as the Louisiana Pharmacist Association Distinguished Young Pharmacist of the Year for his dedication and work for the Pharmacy profession.

Lisa Ellington  
Lisa Ellington, Sr. Manager, Contracts & Chargebacks, , McKesson Corporation